Close Menu
  • Home
  • News
  • Lifestyle
  • Law
  • Business
  • Education

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

Pennsylvania House Passes Cannabis Legalization Bill

May 8, 2025
Facebook X (Twitter) Instagram
Friday, May 9
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Professional
  • Home
  • News

    More Than 1,000 Arrested in Sweep of U.K. Weed Grows

    July 8, 2023

    Scotland Calls On UK To End ‘Failed’ Drug War With Decriminalization And Harm Reduction Approach

    July 8, 2023

    Germany’s draft law for first phase of cannabis reform

    July 8, 2023

    High Times Cannabis Cup Illinois: People’s Choice Edition 2023 Kicks Off

    July 8, 2023

    Pennsylvania Committee Advances Expansion to State Medical Cannabis Program

    July 7, 2023
  • Lifestyle

    How Watching the News Can Trigger Anxiety and Panic Attacks

    October 28, 2024

    Record High Cannabis and Hallucinogen Use Among Adults

    October 27, 2024

    Weekend Sleep Catch-Up May Lower Heart Disease Risk by 20%

    October 27, 2024

    Energy Drinks Linked to Poor Sleep Quality and Insomnia

    October 26, 2024

    First Psychedelic Church for Magic Mushrooms

    October 26, 2024
  • Law

    Pennsylvania House Passes Cannabis Legalization Bill

    May 8, 2025

    Nebraska Lawmakers to Reconsider Bill to Implement Voter-Approved Medical Cannabis Law

    May 7, 2025

    Bill to Legalize Adult-Use Cannabis Filed in Pennsylvania

    May 6, 2025

    New Hampshire Senate Blocks Adult-Use Cannabis Legalization Bill

    May 2, 2025

    Cannabis Taxation: C Corp, S Corp, LLC, LLP, Partnership, Nonprofit, or Something Else for Your Cannabis Business?

    April 30, 2025
  • Business

    California Governor Touts Results of Intoxicating Hemp Ban

    May 9, 2025

    California Governor Touts Results of Intoxicating Hemp Ban

    May 9, 2025

    Cannabis Company CEO Considering New Mexico Gubernatorial Bid

    May 8, 2025

    U.S. Supreme Court Declines to Hear Challenge to Medical Cannabis Advertising Ban

    May 8, 2025

    Minnesota Cannabis Licensing Lotteries Scheduled for June 5

    May 7, 2025
  • Education

    CBD and the Aging Population—What Science Says Today

    March 12, 2025

    Wholesale Nootropic Skincare: Boost Your Product Line

    March 10, 2025

    Ideal for Your Business Needs

    March 8, 2025

    A Must-have For Every Smoke Shop

    March 3, 2025

    The Perfect Addition to Your Product Line

    March 1, 2025
Smoke Professional
You are at:Home»Business»The Medical Community Must Embrace Education 
Business

The Medical Community Must Embrace Education 

adminBy adminMarch 25, 2023No Comments5 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
The Medical Community Must Embrace Education 
Share
Facebook Twitter LinkedIn Pinterest Email
Brain maze concept idea, conceptual art, surreal 3d illustration, abstract painting, graphic design of labyrinth
Illustration: Jorm Sangsorn/ Shuttersrtock

Amid the move toward cannabis legalization in the United States is a major shift in access and use. Approximately three-quarters of Americans now live in states where medical cannabis is legal (including CBD-focused programs like the one in Texas), and nearly half live in states where anyone over the age of twenty-one can access legal cannabis. Around 50 million Americans currently consume cannabis in some manner.

Yet, few healthcare professionals are informed about modern products or how consumers can use them responsibly and effectively for their health. The onus is on the medical community to match consumer use with education and research.

With such a large percentage of the population using cannabis, primary care providers and other clinicians have a pragmatic duty to reduce harm. Healthcare professionals should pursue cannabinoid research and work with patients directly to provide a level of educated support that matches the medical establishment’s knowledge of other widely consumed substances such as caffeine, ibuprofen, and vitamin supplements.

Furthermore, clinicians should understand how other drugs might interact with cannabis and how to mitigate any potential adverse effects. They should be able to discuss which therapeutic routes and formulations—such as ingestible vs. topical—are most appropriate for the patient and the condition, what dosage to recommend, and what to look for when comparing the efficacy of different products. Clinicians also should have an understanding of their state’s medical cannabis program, where applicable. For too long, patients have been reluctant to discuss cannabis with their healthcare providers and instead are forced to search online for answers or rely on potentially dangerous advice casually, if benevolently, offered in dispensaries.

Even with the massive shift in social acceptance and the opening of legal markets, lingering stigma still surrounds the plant. The cultural baggage from the war on drugs weighs heavy, and older generations still see cannabis as a drug of abuse. Evidence of this stigma can be found in the results of 2022 midterm referendums to legalize cannabis in Arkansas, North Dakota, and South Dakota, where voters rejected legalization.

From a clinician’s perspective, there are questions of supporting research and a lack of double-blind, placebo-controlled clinical trials. Clinicians also are simply uneducated, because the endocannabinoid system and cannabinoid-based medicines are not addressed in most mainstream medical-school programs. In addition, most possess no practicing knowledge or experience to inform recommendations, dosages, and frequency.

A data bias also exists because of a lack of funding to study cannabis properly, primarily due to its restricted federal Schedule I status. Prior to the 1990s, there was not a lot of medical literature about the plant. In the ’90s, California’s trailblazing medical cannabis legalization, coupled with the discovery of the human endocannabinoid system, began to generate more interest as scientists realized the potential benefits for a broad range of conditions. Thankfully, the government finally is catching up to this realization, and President Biden recently signed a breakthrough research bill that will ease access to cannabis for study and enable research into potential cannabis-derived medications.

While the passage of the bill is great news for patient advocates, evidence that cannabis medicines are safe and effective already exists. According to a comprehensive research review by the National Academies of Sciences, Engineering, and Medicine, the medical literature suggests cannabis and cannabinoid medicines can provide relief for nausea and chronic pain in adults and have proved effective in mitigating some symptoms of multiple sclerosis. The review also suggests several other ailments for which cannabis may provide modest improvement of symptoms.

With increased acceptance and education, clinicians can look for novel and therapeutic options when patients are not responding to traditional care. And with its extremely high safety profile compared to narcotics and over-the-counter pain medications, cannabis might be considered prior to prescribing addictive opioids or other drugs with debilitating side effects for conditions such as chronic pain.

A standard system of cannabis education is necessary now. With guidelines established by a national healthcare association or medical board, clinicians could receive the guidance necessary to discuss and prescribe cannabis properly. It is time for healthcare professionals to step up and demand the standards of care for patients include cannabis as an option. Meanwhile, medical schools and hospitals across the country must adopt standards for clinical competencies that are similar to other areas of expertise.

We have reached a point where it is unethical for clinicians and medical-education professionals to reject the evidence in the literature. No clinician wants to deny a patient a safe pathway to relief.


Timothy Byars headshot man in suit jacket and blue shirtTimothy Byars is the director of cannabis programs at Pacific College of Health and Science. He is a researcher, writer, and curriculum developer with more than twenty years’ experience writing, editing, and developing content, and he has been active in the cannabis industry since 2014. Byars is the author of Introduction to Cannabis Science: A Primer for Healthcare Professionals, Students, and the Cannabis Curious.

Source link

Community Education embrace medical
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleZurich to legalise adult-use cannabis in pilot project
Next Article South Dakota Governor Vetoes Bill To Increase Hemp THC Limits During Processing
admin
  • Website

Related Posts

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

Cannabis Company CEO Considering New Mexico Gubernatorial Bid

May 8, 2025

Comments are closed.

Our Picks

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

Pennsylvania House Passes Cannabis Legalization Bill

May 8, 2025

Cannabis Company CEO Considering New Mexico Gubernatorial Bid

May 8, 2025
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Business

California Governor Touts Results of Intoxicating Hemp Ban

By adminMay 9, 20250

The Office of California Gov. Gavin Newsom (D) announced on Thursday that the state’s ban…

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

Pennsylvania House Passes Cannabis Legalization Bill

May 8, 2025

Cannabis Company CEO Considering New Mexico Gubernatorial Bid

May 8, 2025

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

California Governor Touts Results of Intoxicating Hemp Ban

May 9, 2025

Pennsylvania House Passes Cannabis Legalization Bill

May 8, 2025
Sponsors
Copyright © 2025. SmokeProfessional
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.